| Literature DB >> 32126618 |
Abstract
BACKGROUND: Extensive eyelid defects are extremely challenging to reconstruct. Although numerous procedures for reconstructing periorbital defects have been proposed, no method is universally used. However, the Tenzel flap is the most commonly used technique to reconstruct eyelid defects affecting one-third to two-thirds of the eyelid.Entities:
Keywords: Eyelids; Skin neoplasms; Surgical flaps
Year: 2020 PMID: 32126618 PMCID: PMC7054187 DOI: 10.7181/acfs.2019.00577
Source DB: PubMed Journal: Arch Craniofac Surg ISSN: 2287-1152
Fig. 1.A 70-year-old man with an 11×6 mm basal cell carcinoma on the medial side of the eyelid-cheek junction (case 1). (A) Preoperative photograph. (B) Intraoperative photograph showing the defect immediately after excision of the tumor. The defect measured 25×15 mm. (C) Flap elevation began at the superior margin of the flap and proceeded caudally. Superiorly, the plane of elevation was just above that of the orbicularis muscle. Dissection proceeded toward the inferolateral corner of the flap in the subcutaneous plane until sufficient flap mobilization was achieved. (D) The patient’s appearance at 20 months after reconstruction. A favorable aesthetic outcome was observed, with a hardly noticeable scar on the lower eyelid and cheek.
Fig. 2.A 60-year-old woman with a 5×5 mm basal cell carcinoma on the lateral upper eyelid (case 2). (A) Preoperative photograph. (B) The flap was elevated in the subcutaneous plane and advanced superomedially to close the defect. (C) Immediate postoperative view of the reconstruction using a modified Tenzel flap. (D) Appearance at 3 weeks after reconstruction. An aesthetically gratifying result was observed, with a natural upper lid line.
General characteristics of the patients and surgical data
| Case no. | Sex | Age (yr) | Histopathologic diagnosis | Dimensions of defect (mm) | Complications | Follow-up period (mo) | |
|---|---|---|---|---|---|---|---|
| Width | Height | ||||||
| 1 | Male | 70 | Basal cell carcinoma | 25 | 12 | None | 28 |
| 2 | Female | 60 | Basal cell carcinoma | 17 | 15 | None | 3 |
| 3 | Male | 69 | Basal cell carcinoma | 13 | 9 | None | 12 |
| 4 | Male | 53 | Basal cell carcinoma | 18 | 12 | None | 7 |
| 5 | Female | 81 | Basal cell carcinoma | 20 | 13 | Epiphora | 3 |
| 6 | Female | 86 | Squamous cell carcinoma | 35 | 25 | None | 3 |
| 7 | Female | 77 | Basal cell carcinoma | 15 | 6 | None | 3 |